July 5, 2024 3-5PM ET

Friday on The Robert Scott Bell Show:

Key to Revolving Door’: FDA Tells Staff Who Leave for Pharma Jobs They Can Work ‘Behind the Scenes’ to Influence Agency The FDA informs departing workers that they can still influence the agency’s decision-making after leaving to work for the pharmaceutical industry, despite legal restrictions on direct lobbying. Internal emails show FDA staff advising employees about “behind-the-scenes” influence, highlighting a critical loophole in U.S. revolving door policy. Experts criticize this practice, stating it undermines public trust and regulatory integrity. Departing FDA staff can engage in activities that allow indirect lobbying, influencing regulatory decisions. Proposed legislation aims to close this loophole, but none have passed. Critics argue the revolving door between regulators and industry compromises the fairness of the regulatory process and benefits private interests over public health. The FDA’s proactive communication about this “behind-the-scenes” work to departing employees raises concerns about regulatory capture and the integrity of public health decisions. Additionally, the article discusses various perspectives from experts who argue that the current regulations do not adequately prevent former employees from leveraging their insider knowledge for the benefit of private sector interests. The potential for conflicts of interest and the undermining of public confidence in regulatory agencies are significant issues highlighted in the investigation.

Ozempic could make you go BLIND warn experts as worrying study finds patients on the drug are more likely to suffer irreversible optic nerve damage Experts warn that semaglutide, a drug marketed as Ozempic and Wegovy, increases the risk of non-arteritic anterior ischemic optic neuropathy (NAION), potentially causing blindness. Studies show diabetic patients on semaglutide are four times more likely to develop NAION, and overweight or obese patients are seven times more likely compared to those on other weight-loss medications. NAION, characterized by sudden, painless vision loss in one eye, has no current treatment, making the findings significant. Researchers emphasize the need for further studies and recommend that physicians discuss these risks with patients. As the use of semaglutide rises, understanding its side effects becomes crucial. The drug’s mechanism involves triggering the body to produce a hormone that affects appetite, but the associated risks with the optic nerve indicate a serious side effect that requires thorough patient evaluation. The research underscores the importance of weighing the benefits and risks of semaglutide, particularly for patients with pre-existing eye conditions. Continued surveillance and more extensive studies are necessary to fully understand the implications of these findings.

Summertime Depression Could Be a Type of Seasonal Affective Disorder Summer SAD, a lesser-known variant of seasonal affective disorder, causes depression during the warm months. Symptoms include irritability,insomnia, and weight loss, contrasting with winter SAD’s lethargy and weight gain. Studies suggest heat and humidity may trigger summer SAD, with high temperatures linked to mood disorders and mental health crises. Although the prevalence is unclear, experts agree climate change could increase its incidence. Treatments are understudied, but cooling methods like air conditioning, cold showers, and possibly heat exposure therapies may offer relief. Recognizing and tracking mood changes related to heat can help manage symptoms. The article highlights the need for further research to understand the triggers and develop effective treatments. It also discusses anecdotal evidence and smaller studies that suggest various approaches to mitigating the impact of high temperatures on mood. Experts recommend practical steps for those affected, such as maintaining a cool environment and staying hydrated. As climate change continues to alter weather patterns, the importance of addressing summer SAD becomes increasingly significant for mental health professionals and patients alike.

Welcome to another enlightening episode of “Homeopathic Hits” on The Robert Scott Bell Show.
Today, we’re focusing on Crotalus Horridus, a homeopathic remedy derived from the venom of the rattlesnake.
Known for its potent effects on hemorrhages and infections, Crotalus Horridus offers a natural approach to managing these serious conditions

Download the  Information Sheet

Hour 2

Special Guest Jonathan Emord

For the past 37 years, Jonathan W. Emord has litigated against the federal bureaucracy, winning over and over again. Ron Paul calls Jonathan “an expert in constitutional theory and history” and “an expert litigator with a long string of legal victories over the federal bureaucracy.” George Noory calls him “a Knight in Shining Armor” and “a warrior out to save our rights.” Congressmen Dan Burton and John Doolittle describe him as “an intellectual warrior for the rights and freedoms of people in America.” Jonathan has a unique, detailed knowledge of the federal bureaucracy, the deep state. He knows how to defeat it. Jonathan graduated from the University of Illinois (BA, political science and history, 1982) and DePaul University College of Law (JD, 1985). He served as an attorney in the Federal Communications Commission during the Reagan administration. A leading constitutional law and litigation expert, he is the author of five critically acclaimed books. He has won more cases against the Food and Drug Administration in federal court than any other attorney in American history, earning him the nickname “FDA Dragon Slayer.” He is a columnist for Townhall.com, PJ Media.com, Americangreatness.com, and the U.S.A. Today Magazine. He frequently appears on national radio and television programs. He is married to Sheryl Emord, and they have two children, twins Justice and Angelica. They reside in Clifton, Virginia.

Historic Ruling Limits FDA Authority The Supreme Court ruled 6-3 to overturn Chevron deference, which had allowed federal agencies to interpret ambiguous statutes for 40 years. This decision limits the FDA’s and other agencies’ powers, making it easier to challenge their interpretations of statutes, potentially benefiting natural health access. While the ruling isn’t retroactive, it is expected to lead to numerous lawsuits challenging agency actions. The ruling affects current regulations, as seen with an injunction on a Labor Department overtime rule. The decision requires Congress to draft more detailed legislation, limiting agencies’ ability to create policy without Congressional direction. Agencies may issue more guidance documents, which are harder to challenge. This ruling is significant for natural health advocates as it increases the ability to contest FDA and FTC actions that restrict natural products. The FDA’s broad interpretation of statutes, particularly concerning the New Dietary Ingredient notification guidance, has been a contentious issue. This ruling may curtail the FDA’s expansive regulatory reach, providing a more favorable environment for natural health products and limiting Big Pharma’s and Big Food’s market dominance.

Trump immunity case: Supreme Court rules ex-presidents have substantial protection from prosecution The Supreme Court ruled that former presidents have substantial immunity from prosecution for official actscommitted while in office but not for unofficial acts. In a 6-3 decision, the court clarified that presidents cannot be prosecuted for their core constitutional powers. This decision stems from Special Counsel Jack Smith’s investigation into Trump’s actions related to the 2020 election and the January 6 Capitol riot. Trump pleaded not guilty and argued for immunity from prosecution for his official acts. The ruling has significant implications for future presidents, with justices expressing concerns about the potential for political retribution and destabilization. Justice Sotomayor, in dissent, argued that no one is above the law, while Justice Thomas questioned the legality of the special counsel’s appointment. This ruling underscores the balance between holding presidents accountable and protecting the executive branch’s independence. The court’s decision allows Trump to campaign without legal hindrance but raises ongoing debates about the extent of presidential immunity and the potential for future legal challenges.

The world is sitting on a $91 trillion problem. ‘Hard choices’ are coming Governments worldwide owe an unprecedented $91 trillion, nearly equal to the global economy’s size, posing a growing threat to living standards. This debt burden, exacerbated by the pandemic, is causing concern among investors and policymakers. The International Monetary Fund has warned that chronic fiscal deficits, particularly in the US, must be urgently addressed. Rising debt servicing costs reduce funds for public services and crisis responses, while higher borrowing costs hurt economic growth. Tackling America’s debt problem will require either tax hikes or cuts to benefits like social security and health insurance programs. Politicians, however, are largely avoiding these hard choices. In countries like France, political turmoil has worsened debt concerns, leading to higher bond yields. Germany faces infighting over debt limits, while Kenya has seen protests over proposed tax hikes. The UK’s recent financial crisis, triggered by unfunded tax cuts, highlights the risks of ignoring debt issues. Economists agree that painful adjustments are necessary, with growing debt threatening economic stability and requiring governments to make difficult fiscal decisions to avert future crises.

Biden says he’s ‘first black woman to serve with a black president’ in latest gaffe President Biden described himself as the “first black woman to serve with a black president” during an interview on Philadelphia’sWURD black radio station, marking his latest verbal slip. This gaffe occurred as he discussed his tenure as vice president under Barack Obama and his selection of Kamala Harris as vice president. Biden also boasted about appointing Ketanji Brown Jackson to the Supreme Court. The interview, intended to reassure voters after a problematic debate performance, included other mistakes, such as claiming he was the “first president that got elected statewide in Delaware” as a child and comparing his understanding of the black struggle for representation to Catholics’ challenges before JFK’s presidency. These lapses have raised concerns about Biden’s age and cognitive abilities. Despite the gaffes, Biden’s re-election campaign defended him, arguing that such speech patterns have been typical for Biden throughout his career.

For Joe Biden, What Seems Like Age Might Instead Be Style Joe Biden’s presidency has highlighted his age, but it can also be seen as a distinct phase in his political career, similar to late style in art and literature. Biden’s current demeanor contrasts with his earlier, more energetic persona, reflecting a solemnity and confidence. This change is compared to artistic late styles, where creators revisit themes with new perspectives or create radically different works. Biden’s style now embodies a blend of past experiences and present awareness, emphasizing the fragility of democracy and the need for its preservation. His late style focuses on addressing the rupture in American politics and maintaining democratic values, casting him as a seasoned representative rather than a savior.

Remember Friends, The Power to Heal is Yours!

What would you like to hear from The Robert Scott Bell Show? Call us at 1-866-939-BELL (2355) and let your voice be heard!

Previous episodes of the Robert Scott Bell Show: SoundCloud

Learn the best ways to keep your family fed when the trucks have stopped, the stores shut down, and no food is available. Go to http://RSBFood.com